Drreddys Laboratories | RDY - Assets


Drreddys Laboratories reported INR579.35B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
ANI Pharmaceuticals USD 1.42B 18.41M Mar/2026
Aurora Cannabis CAD 601.09M 174.2M Mar/2026
Bayer EUR 107.94B 3.4B Mar/2026
Canopy Growth CAD 1.12B 12.54M Mar/2026
Cipla INR 424.96B 23.32B Mar/2026
Corcept Therapeutics USD 814.88M 21.77M Mar/2026
Drreddys Laboratories INR 579.35B 573.08B Mar/2026
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lonza CHF 18.97B 164M Dec/2025
Novartis USD 118.53B 7.58B Mar/2026
Pacira USD 1.21B 56.38M Mar/2026
Phibro Animal Health USD 1.45B 39.56M Mar/2026
Prestige Brands USD 3.49B 430K Mar/2026
Richter Gedeon HUF 1.76T 79.96B Mar/2026
Sun Pharmaceuticals INR 1.09T 50.79B Mar/2026
Supernus Pharmaceuticals USD 1.5B 48.08M Mar/2026
Teva Pharmaceutical Industries USD 40.04B 708M Mar/2026